|
|
|
Insider
Information: |
Maduck Sean |
Relationship: |
|
City: |
Menlo Park |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
85,083 |
|
Indirect Shares
|
20,000 |
|
|
Direct
Value |
$3,743,652 |
|
|
Indirect Value
|
$880,000 |
|
|
Total
Shares |
105,083 |
|
|
Total
Value |
$4,623,652 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Corcept Therapeutics Inc |
CORT |
|
2024-09-03 |
85,083 |
2024-09-03 |
20,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
67 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CORT |
Corcept Therapeutics Inc |
See Remarks |
|
2022-08-09 |
4 |
OE |
$1.92 |
$384 |
D/D |
200 |
40,224 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
See Remarks |
|
2022-08-09 |
4 |
AS |
$28.70 |
$5,740 |
D/D |
(200) |
40,024 |
0 |
% |
|
CORT |
Corcept Therapeutics Inc |
See Remarks |
|
2024-09-03 |
4 |
D |
$35.30 |
$8,190 |
D/D |
(232) |
84,167 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
See Remarks |
|
2022-08-19 |
4 |
D |
$27.60 |
$11,206 |
D/D |
(406) |
54,618 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
See Remarks |
|
2024-03-01 |
4 |
D |
$24.06 |
$12,150 |
D/D |
(505) |
73,950 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
See Remarks |
|
2022-12-01 |
4 |
AS |
$25.28 |
$15,800 |
D/D |
(625) |
56,462 |
0 |
% |
|
CORT |
Corcept Therapeutics Inc |
See Remarks |
|
2022-12-01 |
4 |
OE |
$3.29 |
$2,056 |
D/D |
625 |
57,087 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Chief Commercial Officer |
|
2021-10-05 |
4 |
AS |
$20.00 |
$12,740 |
D/D |
(637) |
40,024 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Chief Commercial Officer |
|
2021-10-05 |
4 |
OE |
$3.29 |
$2,096 |
D/D |
637 |
40,661 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
See Remarks |
|
2024-06-03 |
4 |
D |
$30.17 |
$24,830 |
D/D |
(823) |
84,399 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
See Remarks |
|
2023-09-01 |
4 |
A |
$0.00 |
$15,094 |
D/D |
912 |
73,610 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
See Remarks |
|
2024-09-03 |
4 |
A |
$0.00 |
$15,691 |
D/D |
916 |
85,083 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
See Remarks |
|
2023-12-01 |
4 |
A |
$0.00 |
$15,115 |
D/D |
1,164 |
74,455 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
See Remarks |
|
2024-03-01 |
4 |
A |
$0.00 |
$15,302 |
D/D |
1,272 |
75,222 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
See Remarks |
|
2022-09-01 |
4 |
A |
$0.00 |
$23,954 |
D/D |
1,844 |
56,462 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
See Remarks |
|
2023-03-01 |
4 |
A |
$0.00 |
$28,996 |
D/D |
2,920 |
59,382 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
See Remarks |
|
2023-10-02 |
4 |
OE |
$3.02 |
$9,154 |
D/D |
3,031 |
76,641 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
See Remarks |
|
2023-10-02 |
4 |
AS |
$27.24 |
$82,577 |
D/D |
(3,031) |
73,610 |
0 |
% |
|
CORT |
Corcept Therapeutics Inc |
See Remarks |
|
2023-06-01 |
4 |
A |
$0.00 |
$38,084 |
D/D |
3,316 |
62,698 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
See Remarks |
|
2021-02-11 |
4 |
S |
$29.78 |
$101,249 |
D/D |
(3,400) |
30,024 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
See Remarks |
|
2021-02-11 |
4 |
OE |
$3.29 |
$11,186 |
D/D |
3,400 |
33,424 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
See Remarks |
|
2023-10-06 |
4 |
AS |
$27.24 |
$95,286 |
D/D |
(3,498) |
73,610 |
0 |
% |
|
CORT |
Corcept Therapeutics Inc |
See Remarks |
|
2023-10-06 |
4 |
OE |
$3.02 |
$10,564 |
D/D |
3,498 |
77,108 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
See Remarks |
|
2024-02-15 |
4 |
OE |
$3.29 |
$15,660 |
D/D |
4,760 |
79,215 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
See Remarks |
|
2024-02-15 |
4 |
AS |
$25.00 |
$119,000 |
D/D |
(4,760) |
74,455 |
0 |
% |
|
67 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|